Performance of the SF-36, SF-12, and RAND-36 summary scales in a multiple sclerosis population

Medical Care

Volumn 38, Issue 10, 2000, Pages 1022-1028

  Nortvedt, Monica W ^a   Riise, Trond ^a   Myhr, Kjell Morten ^b   Nyland, Harald I ^b  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Multiple sclerosis; Quality of life; RAND 36 health status inventory; SF 12 health survey; SF 36 health survey; Summary scales

Indexed keywords

ARTICLE; CROSS-SECTIONAL STUDY; DAILY LIFE ACTIVITY; DISABILITY; FEMALE; HEALTH SURVEY; HUMAN; MALE; MENTAL HEALTH; METHODOLOGY; MIDDLE AGED; MULTIPLE SCLEROSIS; NORWAY; OUTCOME ASSESSMENT; QUALITY OF LIFE; REPRODUCIBILITY;

ACTIVITIES OF DAILY LIVING; CROSS-SECTIONAL STUDIES; DISABILITY EVALUATION; FEMALE; HEALTH STATUS INDICATORS; HUMANS; MALE; MENTAL HEALTH; MIDDLE AGED; MULTIPLE SCLEROSIS; NORWAY; OUTCOME ASSESSMENT (HEALTH CARE); QUALITY OF LIFE; REPRODUCIBILITY OF RESULTS;

EID: 0034297046     PISSN: 00257079     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005650-200010000-00006     Document Type: Article

References (28)

1. Matthews WB. Clinical aspects. In: Compston DAS, ed. McAlpine's multiple sclerosis. London, UK: Churchill-Livingstone; 1998:43-251.
2. Brønnum-Hansen H, Koch-Henriksen N, Hyllested K. Survival of patients with multiple sclerosis in Denmark: A nationwide, long-term epidemiologic survey. Neurology 1994;44:1901-1907.
3. Riise T, Grønning M, Aarli JA, et al. Prognostic factors for life expectancy in multiple sclerosis analyzed by Cox models. J Clin Epidemiol 1988;41:1031-1036.
4. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology 1983;33:1444-1452.
5. Whitaker JN, McFarland HF, Rudge P, et al. Outcomes assessment in multiple sclerosis clinical trials: A critical analysis. Mult Scler 1995;1:37-47.
6. Brunet DG, Hopman WM, Singer MA, et al. Measurement of health-related quality of life in multiple sclerosis patients. Can J Neurol Sci 1996;23:99-103.
7. Cutter GR, Baier ML, Rudick RA, et al. Development of multiple sclerosis functional composite as a clinical outcome measure. Brain 1999;122:871-882.
8. Ware JE, Snow KK, Kosinski M, et al. SF-36 Health Survey manual and interpretation guide. Boston, Mass: New England Medical Center, Health Institute; 1993.
9. Canadian Burden of Illness Study Group. Burden of illness of multiple sclerosis, II: Quality of life. Can J Neurol Sci 1998;25:31-38.
10. Nortvedt MW, Riise T, Myhr KM, et al. Quality of life in multiple sclerosis: Measuring the disease effects more broadly. Neurology 1999;53:1098-1103.
11. Nortvedt MW, Riise T, Myhr KM, et al. Type I interferons and the quality of life of MS patients: Results from a clinical trial on interferon alfa-2a. Mult Scler 1999;5:317-322.
12. Nortvedt MW, Riise T, Myhr KM, et al. Quality of life as a predictor for change in disability in MS. Neurology In press.
13. Ware JE, Kosinski M, Keller SD. SF-36 phys ical and mental health summary scales: A user's manual. Boston, Mass: New England Medical Center, Health Institute; 1994.
14. Ware JE, Kosinski M, Bayliss MS, et al. Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: Summary of results from the Medical Outcomes Study. Med Care 1995;33:AS264-AS279.
15. Simon GE, Revicki DA, Grothaus L, et al. SF-36 summary scores: Are physical and mental health truly distinct? Med Care 1998;4:567-572.
16. Ware JE, Kosinski M, Keller SD. SF-12: How to score the SF-12 physical and mental health summary scales. Boston, Mass: New England Medical Center, Health Institute; 1995.
17. Hays RD, Prince-Embury S, Chen H. RAND-36 Health Status Inventory. San Antonio, Tex: Psychological Corp; 1998.
18. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols. Ann Neurol 1983;13:227-231.
19. Kurtzke JF. A proposal for a uniform minimal record of disability in multiple sclerosis. Acta Neurol Scand 1981;64(suppl 87):110-129.
20. Kurtzke JF. Disability rating scales in multiple sclerosis. Ann N Y Acad Sci 1984;436:347-360.
21. Loge JH, Kaasa S, Hjermstad MJ, et al. Translation and performance of the Norwegian SF-36 Health Survey in patients with rheumatoid arthritis, I: Data quality, scaling assumptions, reliability and construct validity. J Clin Epidemiol 1998;51:1069-1076.
22. Brazier JE, Harper R, Jones NMB, et al. Validating the SF-36 Health Survey questionnaire: New outcome measure for primary care. BMJ 1992;305:160-164.
23. Gandek B, Ware JE, Aaronson NK, et al. Cross-validation of item selection and scoring for the SF-12 health survey in nine countries: Results from the IQOLA project. J Clin Epidemiol 1998;11:1171-1178.
24. Ware JE, Kosinski M, Keller SD. A 12-item, short-form health survey: Construction of scales and preliminary tests of reliability and validity. Med Care 1996;3:220-223.
25. McIvor GP, Riklan M, Reznikoff M. Depression in multiple sclerosis as a function of length and severity of illness, age, remissions, and perceived social support. J Clin Psychol 1984;40:1028-1033.
26. Midgard R, Riise T, Nyland H. Impairment, disability, and handicap in multiple sclerosis: A cross-sectional study in an incident cohort in Møre and Romsdal County, Norway. J Neurol 1996;243:337-344.
27. Hays RD, Marshall GN, Wang EY, et al. Four-year cross-lagged associations between physical and mental health in the Medical Outcomes Study. J Consult Clin Psychol 1994;62:441-449.
28. Hays RD, Cunningham WE, Ettl MK, et al. Health-related quality of life in HIV disease. Assessment 1995;2:363-380.